A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients
Clinical trial NCT02825563 · COMPLETED
Trial details
- NCT number
- NCT02825563
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-08-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.